ALA
Arovella Therapeutics Limited
🇦🇺 ASX
📈 HIGH PRICE GROWTH
📦 LOGISTICS
👑 Overview
📈 Performance
💵 Cost
🤓 Advanced
👨👩👧👦 Community
📈
+ 46.89%
Annual Growth
5 years average annual growth
💵
$ 500
Minimum Order
Due to regulatory requirements
🌏
9
Pearlers Invested
Since January 2020
👑 Overview
Key information
🔎 Fund Overview
Arovella Therapeutics Ltd. engages in the development invariant Natural Killer (iNKT) cell platform for treatment of cancer. The firm is focused on developing its invariant natural killer T (iNKT) cell therapy platform from Imperial College London to treat blood cancers and solid tumors. The firm's lead product is ALA-101. ALA-101 is being developed as an allogeneic cell therapy, which means it can be given from a healthy donor to a patient. ALA-101 is a next-generation CAR-iNKT cell therapy that targets CD19+ B cell lymphomas and leukemias. ALA-101 consists of CAR19-iNKT cells that have been modified to produce a Chimeric Antigen Receptor (CAR) that targets CD19. CD19 is an antigen found on the surface of numerous cancer types. The firm is also engaged in expanding solid tumor treatment through its CLDN18.2-targeting technology licensed from Sparx Group. Its iNKT cells also contain an invariant T cell receptor (iTCR) that targets alpha-galactosylceramide (a-GalCer) bound CD1d, another antigen found on the surface of several cancer types.
📈 Performance
Price History
+258.32%
1M
1Y
10Y
Graph
Table
Unsure how much or often to invest?
🗓️ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out →💵 Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out →⏱️ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out →💵 Costs
💼
N/A
Management Fee
Included in unit price, not charged by Pearler
💸
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator🤓 Advanced information
Technical Info
💰 Price*
$0.17
*Price may be up to 24 hours old
👩👩👦 Community Insights
How our community is investing
🌏 Pearlers invested in ALA
9
📊 Total Capital Earnings
$84K
🔃 Average investment frequency
37 weeks
💵 Average investment amount
$1,713
⏰ Last time a customer invested in ALA
6 days
ALA investor breakdown
💵 Income of investors
More than 200k
150k - 200k
20%
100k - 150k
20%
50k - 100k
50%
Less than 50k
10%
👶 Age of investors
18 - 25
26 - 34
67%
35 - 90
33%
🙋 Legal gender of investors
Female
67%
Male
33%
Pearlers who invest in ALA also invest in...
IVV
IVV.AX was created on 2007-10-10 by iShares. The fund's investment portfolio concentrates primarily on large cap equity. The Fund aims to provide investors with the performance of an index, before fees and expenses. The index is designed to measure the performance of large capitalisation US equities.
🙌 Performance (5Yr p.a)
20.56%
📊 Share price
$63.57 AUD
📈 HIGH PRICE GROWTH
🇺🇸 UNITED STATES
VAS.AX was created on 2009-05-04 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard Australian Shares Index ETF seeks to track the return of the S&P/ASX 300 Index before taking into account fees, expenses and tax.
🙌 Performance (5Yr p.a)
3.56%
📊 Share price
$101.86 AUD
🇦🇺 AUSTRALIA
⛳️ DIVERSIFIED
🧱 MATERIALS
💸 FINANCIALS
VDHG.AX was created on 2017-11-20 by Vanguard. The fund's investment portfolio concentrates primarily on target outcome asset allocation. Vanguard Diversified High Growth Index ETF seeks to track the weighted average return of the various indices of the underlying funds in which it invests, in proportion to the Strategic Asset Allocation, before taking into account fees, expenses and tax.
🙌 Performance (5Yr p.a)
3.79%
📊 Share price
$68.90 AUD
🌏 GLOBAL
⛳️ DIVERSIFIED
VGS.AX was created on 2014-11-18 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard MSCI International Shares Index ETF seeks to track the return of the MSCI World ex-Australia Index (with net dividends reinvested) in Australian dollars before taking into account fees, expenses and tax.
🙌 Performance (5Yr p.a)
14.02%
📊 Share price
$140.20 AUD
⛳️ DIVERSIFIED
📈 HIGH PRICE GROWTH
🌏 GLOBAL
🤖 TECHNOLOGY
ACDC.AX was created on 2018-08-30 by Global X. The fund's investment portfolio concentrates primarily on theme equity. The Fund aims to provide investors with a return that (before fees and expenses) tracks the performance of the Solactive Battery ValueChain Index (the Index).
🙌 Performance (5Yr p.a)
13.71%
📊 Share price
$87.09 AUD
🌏 GLOBAL
🛍️ CONSUMER
📈 HIGH PRICE GROWTH
🏭 INDUSTRIALS
Want more shares? Try these...
Albion Resources Ltd. is focused on exploration for lead, zinc, gold, and nickel. The company is headquartered in Perth, Western Australia. The company went IPO on 2021-04-30. The firm's projects include Mongers Lake Project, Leinster Project and Lennard Shelf Project. The Mongers Lake Project covers a portion of the Yalgoo-Singleton Greenstone Belt in the Murchison Province of Western Australia, located between Capricorn Metals’ Mt Gibson Gold Project and Silver Lakes’ Rothsay Gold Projects. The firm has identified three prospect areas: Rothsay South, Red Well and Clay Pan. The Leinster Project, located 30 kilometers (kms) southeast of Leinster, covers an area of approximately 42 square kilometers (km2) and is prospective for nickel-copper being located adjacent to BHP's Nickel West Weebo Ni deposit. The Lennard Shelf Project is located in the Mississippi Valley type Zinc-Lead province, the Lennard Shelf, approximately 30 kms southeast of Fitzroy Crossing in the Kimberley, Western Australia.
📊 Share price
$0.04 AUD
⛏️ MINING
Alcidion Group Ltd. engages in the development and provision of healthcare software products marketed under the Miya, Patientrack, Smartpage and ExtraMed brands. The company is headquartered in Melbourne, Victoria. The company went IPO on 2011-06-24. The firm's principal activities include the development and licensing of its own healthcare software products (Miya Precision and its associated modules, including Miya Observations, Flow, Task Management and PAS), the reselling of selected healthcare software products from its strategic partners and the delivery of product implementation, product support and maintenance, systems integration, and data analysis services to healthcare customers in Australia, New Zealand, and the United Kingdom. Its product, Miya Precision, is a smart clinical solution based on a FHIR-event platform that facilitates multiple clinical and operational applications. The firm's other products include Smartpage, Patientrack, and Silverlink PCS. Smartpage is an advanced smartphone and Web-based system for hospital communication and task management, addressing the requirements of both clinical and non-clinical users.
🙌 Performance (5Yr p.a)
-13.20%
📊 Share price
$0.06 AUD
🩺 HEALTH CARE
Audio Pixels Holdings Ltd. engages in the business of developing digital speakers. The company is headquartered in Sydney, New South Wales and currently employs 14 full-time employees. The company went IPO on 2004-12-24. The firm invests in Audio Pixels Limited of Israel. The Company, through its subsidiary, Audio Pixels Limited, is engaged in the development of digital speakers. The Company’s patented technologies employ new techniques to generate sound waves directly from a digital audio stream using low-cost micro-electromechanical structures (MEMS). The Company’s MEMS-based Digital Sound Reconstruction platform enables the market for audio speakers to follow the evolution of the video display market from large, heavy analog tube-based monitors to digital flat panel displays.
🙌 Performance (5Yr p.a)
-12.17%
📊 Share price
$6.20 AUD
🛍️ CONSUMER
AML3D Ltd. engages in the provision of 3D printing services and machinery. The company is disrupting metal part supply chains using the Company’s patented Wire Additive Manufacturing (WAM) process. WAM combines welding science, robotics automation, materials engineering and proprietary software to lead metal additive manufacturing globally. The company is the original equipment manufacturer (OEM) of the ARCEMY industrial metal 3D printing systems. ARCEMY uses WAM to provide advanced, automated, on-demand, point-of-need 3D manufacturing solutions that are more efficient, cost-effective and have ESG outcomes compared to traditional casting, forging and billet machining processes. ARCEMY is the Internet of Things (IoT) and Industry 4.0 enabled to allow manufacturers across aerospace, defense, maritime, manufacturing, mining and oil & gas to become globally competitive. The company also provides metal 3D printing design engineering services, software licensing, technical support, consumable sales and contract manufacturing services.
📊 Share price
$0.16 AUD
🚜 MACHINERY